Mexico Healthcare news | Sharemaestro Newsreel

20:58 12 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇲🇽 Mexico

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

MRK mentioned

Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6%

20:30 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

These Are the Stocks Wall Street Is Betting Against the Most

This article first appeared on GuruFocus. The supplied source only contains the heatmap headline and ticker list, without the underlying short-interest percentages or ranking data. I can write the story accurately from that limited information, but I would not invent figures. A group of …

RXRX mentioned

Sharemaestro market context Price below Trend Line 52 weeks -48.1% · Next-week setup negative 27.6%

19:38 12 Aug 2026

seekingalpha.com Earnings Main company 🇲🇽 Mexico

Altimmune outlines PERFORMA Phase III MASH 52-week data readout expected in 2029 while advancing AUD Phase III planning

Earnings Call Insights: Altimmune (ALT) Q2 2026 MANAGEMENT VIEW * "2026 is proving to be a year of significant progress as Altimmune evolves into a late-stage company dedicated to serious liver diseases," said Chairman, CEO & President Jerome Durso, adding, "Last week we announced …

ALT1 main company

Sharemaestro market context Price below Trend Line 52 weeks -27.6% · Next-week setup negative 17.4%

19:36 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:36 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

Bristol Myers Squibb BMY is navigating a revenue mix shift as growth products portfolio now assumes a larger role in the business, helping mitigate the impact of declining sales from mature products facing generics. The growth portfolio — including Opdivo, Opdivo Qvantig, Orencia, Yervoy, …

MRK mentioned PFE mentioned BMY mentioned

Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6%

19:34 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

ISRG main company GMED mentioned

Sharemaestro market context Price below Trend Line 52 weeks -27.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

DXCM main company ABT mentioned

Sharemaestro market context Trend signal active 52 weeks -5.0% · Next-week setup negative 22.9%

19:33 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Can UNH's Lower Medical Costs Sustain the Earnings Recovery?

UnitedHealth Group Incorporated's UNH second-quarter results show that its earnings performance is improving. The medical care ratio (MCR) fell to 86.7% from 89.4% a year ago, meaning the company spent less of its premium revenues on medical care and retained more for profits. This …

UNH mentioned CVS mentioned

Sharemaestro market context Trend signal active 52 weeks +21.8%

19:13 12 Aug 2026

finance.yahoo.com Deals and strategy Main company 🇲🇽 Mexico

Gilead Sciences (GILD) Expands ADC Research With AI Tissue Analytics

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Gilead Sciences (NasdaqGS:GILD) announced a partnership with Nucleai to use AI-powered tissue analytics in its global antibody drug conjugate programs. The collaboration focuses …

GILD main company

Sharemaestro market context Price below Trend Line 52 weeks +4.3%

18:31 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Sandbox VR Continues to Expand with its First North Carolina Venue in Winston-Salem, Opening August 14

Sandbox VR brings the 'best virtual reality experience on the planet' to Downtown Winston-Salem WINSTON-SALEM, N.C., Aug. 12, 2026 /PRNewswire/ -- Sandbox VR, the world's premier venue for virtual reality experiences, is set to open its first North Carolina location on August 14, 2026. …

CVS mentioned

Sharemaestro market context Trend signal active 52 weeks +45.1%

18:30 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

18:29 12 Aug 2026

finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish drugmaker behind Wegovy and Ozempic, fell 2.23% intraday after Berenberg downgraded the stock to Hold from Buy, cutting its Copenhagen target to DKK 305 from DKK 325 and its ADR target to $47 …

NOVOBN main company NVON main company LLY mentioned

Sharemaestro market context Price above Trend Line 52 weeks -15.6%

18:24 12 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Eli Lilly Stock Falls While Retatrutide Lawsuits Expand

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the drug giant sitting at the center of the obesity boom, filed six lawsuits against businesses it says are illegally selling retatrutide. The timing is striking. Retatrutide is not approved. It is still in Phase …

LLY main company

Sharemaestro market context Trend signal active 52 weeks +54.2%

18:20 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

JNJ mentioned GMED mentioned

Sharemaestro market context Trend signal active 52 weeks +32.5%

18:11 12 Aug 2026

finance.yahoo.com Deals and strategy Provider-linked mention 🇲🇽 Mexico

Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Absci (ABSI) is back in focus after releasing early Phase 1 data for its lead antibody ABS-201 and securing a US$40 million investment and development …

LLY mentioned

Sharemaestro market context Trend signal active 52 weeks +54.2%

17:54 12 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Lilly Targets Black-Market Retatrutide Sellers

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the pharmaceutical company behind Zepbound and Foundayo, is stepping up its fight against unauthorized sellers of its experimental obesity drug retatrutide. Warning! GuruFocus has detected 8 Warning Sign with JPM. Is LLY …

LLY main company

Sharemaestro market context Trend signal active 52 weeks +54.2%

17:16 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

CVS Health (CVS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Vice President of Capital Markets - Larry McGrath Chair and Chief Executive Officer - David Joyner Chief Financial Officer - Brian Newman Full Conference Call Transcript Operator: …

CVS main company

Sharemaestro market context Trend signal active 52 weeks +45.1%

17:12 12 Aug 2026

finance.yahoo.com Balance sheet Provider-linked mention 🇲🇽 Mexico

The Energy and Pharma Giants Quietly Funding HDV’s 3% Yield, and How Safe Each One Is

Quick Read XOM and JNJ earn 'Very Safe' dividend ratings inside HDV, backed by interest coverage of 56x and 64 consecutive annual raises. AbbVie's Skyrizi and Rinvoq are replacing Humira faster than expected, but Net Debt/EBITDA of 2.3x keeps a watchlist tag on its …

JNJ mentioned ABBV mentioned

Sharemaestro market context Trend signal active 52 weeks +32.5%

17:11 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Johnson & Johnson (JNJ) Advances Seltorexant And Expands Outpatient Cardiac Care

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Johnson & Johnson (NYSE: JNJ) is advancing its novel antidepressant Seltorexant into late stage clinical development for major depressive disorder as a potential rapid …

JNJ main company

Sharemaestro market context Trend signal active 52 weeks +32.5%

17:00 12 Aug 2026

finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know

GE HealthCare Technologies (GEHC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A …

GEHC main company

Sharemaestro market context Price below Trend Line 52 weeks -11.3%

16:55 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Nextensa delivers strong half-year results, supported by several successful transactions

Nextensa NV PRESS RELEASE Regulated information Brussels, 12 August 2026, 5:55PM HIGHLIGHTS Nextensadeliversstronghalf-yearresults,supportedbyseveralsuccessful transactions Nextensa achieved strong results in the first half of 2026. The period was marked by several successful transactions, including the sale of Gewerbepark Stadlau in Vienna, the forward sale of …

BAYNN mentioned

Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6%

16:41 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …

COO mentioned GMED mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.9% · Next-week setup negative 25.0%

16:40 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

BMRN vs. ILMN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Illumina (ILMN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. …

BMRN main company

Sharemaestro market context Price below Trend Line 52 weeks -13.4% · Next-week setup negative 8.0%

16:36 12 Aug 2026

finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -27.9%

16:25 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 2.6% in the morning session after an analyst at Canaccord Genuity raised the company's price target to $114 from $111 and maintained a …

BMRN main company

Sharemaestro market context Price below Trend Line 52 weeks -13.4% · Next-week setup negative 8.0%

16:22 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace, Inc. NPCE reported a second-quarter 2026 loss per share of 18 cents, compared with a loss of 30 cents in the year-ago period. The figure beat the Zacks Consensus Estimate by 5.3%. Shares of NPCE were down approximately 2.3% during after-market trading following …

COO mentioned GMED mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.9% · Next-week setup negative 25.0%

16:11 12 Aug 2026

finance.yahoo.com Deals and strategy Main company 🇲🇽 Mexico

Is Bristol Myers’ US$2.3 Billion Houston Manufacturing Campus Altering The Investment Case For BMY?

Bristol Myers Squibb recently announced it will invest about US$2.30 billion in a new 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, Texas, expected to support production of small molecules, biologics, and antibody-drug conjugates while creating nearly 500 skilled jobs and about …

BMY main company

Sharemaestro market context Trend signal started 52 weeks +23.9%

16:10 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock?

Novo Nordisk NVO stock has declined 4% over the past month, with the company's second-quarter 2026 results emerging as the primary factor behind the recent weakness. Although NVO beat earnings and revenue estimates, investors remained concerned about underlying growth trends in its core obesity …

NOVOBN main company NVON main company LLY mentioned

Sharemaestro market context Price above Trend Line 52 weeks -15.6%

16:03 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?

Pfizer's PFE business mix has changed significantly over the past few years. During the pandemic, the company became heavily dependent on COVID-19 products, Comirnaty (COVID-19 vaccine) and Paxlovid (oral antiviral). However, the company is gradually diversifying its portfolio through a combination of internal product …

PFE main company LLY mentioned BMY mentioned

Sharemaestro market context Price above Trend Line 52 weeks -2.9%

16:02 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says

Vertex Pharmaceuticals (VRTX) has multiple potential catalysts coming from its portfolio that provide a net positive risk-reward profile for the company, RBC Capital Markets said in a Wednesday note.The company is expected to present results from its phase 1 study of VX-828 in Silver …

VRTX main company

Sharemaestro market context Trend signal active 52 weeks +13.2%

15:46 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses

Tango Therapeutics TNGX incurred a loss of 37 cents per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of 31 cents. The company had reported a loss of 35 cents per share in the year-ago quarter. …

GILD mentioned

Sharemaestro market context Price below Trend Line 52 weeks +4.3%

15:35 12 Aug 2026

nasdaq.com Analyst action Provider-linked mention 🇲🇽 Mexico

1 Vanguard ETF That Outperforms the S&P 500 and Still Has Room to Run

Key Points The "Magnificent Seven" stocks account for over 53% of this Vanguard ETF. This has helped the ETF outperform the S&P 500 in 13 of the past 20 years. Sluggish performance among its top 10 holdings has slowed returns this year.10 stocks we …

LLY mentioned

Sharemaestro market context Trend signal active 52 weeks +54.2%

15:29 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Obesity-drug giant Eli Lilly stock is approaching a new buy point as the ongoing stock market rally strengthens. Continue Reading

LLY mentioned

Sharemaestro market context Trend signal active 52 weeks +54.2%

15:21 12 Aug 2026

seekingalpha.com Regulatory and legal Main company 🇲🇽 Mexico

Summit higher as partner Akeso wins China label expansion for lead drug

[Approved red stamp sign.] * Shares of Summit Therapeutics (SMMT [https://seekingalpha.com/symbol/SMMT]) traded higher on Wednesday after the Chinese drug regulator, the National Medical Products Administration, approved a label expansion for the company’s lead drug, ivonescimab, developed with Akeso (AKESF [https://seekingalpha.com/symbol/AKESF]). * According to Summit …

SMMT main company

Sharemaestro market context Price below Trend Line 52 weeks -31.8% · Next-week setup negative 7.6%